EARLY AND LATE POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA

被引:0
|
作者
Strachuk, Alexandr [1 ]
Pashina, Nataliya [2 ]
Korovyakova, Elina [1 ]
Chechetkina, Yana [1 ]
Karaseva, Natalia [1 ]
Pashin, Sergej [2 ]
Alhejoj, Hasan [1 ]
Hakobova, Rebeka [1 ]
Kabardokov, Tamerlan [1 ]
机构
[1] Peoples friendship Univ Russia, RUDN Univ, Moscow, Russia
[2] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源
ARCHIV EUROMEDICA | 2021年 / 11卷 / 03期
关键词
renal cell carcinoma; bleeding; postoperative complications; nephrectomy; advanced lymphadenectomy;
D O I
10.35630/2199-885X/2021/11/3/9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Modern Russian statistics show that the percentage of renal cell carcinoma (RCC) among all oncological diseases has increased and amounted to almost 5% in 2019. The main method of treating RCC is radical nephrectomy in localized RCC, which is supplemented by the removal of regional lymph nodes in locally advanced RCC. AIM: To evaluate early and late postoperative complications in patients with localized and locally advanced renal cell carcinoma. METHODS: We've analyzed the results of surgical treatment and postoperative complications in 378 patients with clinically proven localized and locally developed RCC. RESULTS: The total number of complications after surgical treatment of patients with localized and locally advanced RCC was 24 (6.3%) patients. Moreover, in the treatment of the localized form of RCC, postoperative complications are 3 times less common than in the locally advanced form of RCC (p <0.05). The most common complication after surgical treatment of RCC was bleeding which we observed in 11(2.9%) patients. CONCLUSION: After surgical treatment of RCC, the proportion of complications is not high, but they can have unpleasant consequences. In the late postoperative period the most common complication bleeding is followed by lymphorrhea and urinary tract infections.
引用
收藏
页码:33 / 35
页数:3
相关论文
共 50 条
  • [21] Adjuvant immunotherapy for locally advanced renal cell carcinoma
    Alevizakos, Michail
    Mcdermott, David
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (12) : 1265 - 1275
  • [22] POSTOPERATIVE COMPLICATIONS EARLY AND LATE
    JAFFE, NS
    TRANSACTIONS AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTOLARYNGOLOGY, 1976, 81 (01): : O118 - O119
  • [23] Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives
    Berquist, Sean W.
    Yim, Kendrick
    Ryan, Stephen T.
    Patel, Sunil H.
    Eldefrawy, Ahmed
    Cotta, Brittney H.
    Bradshaw, Aaron W.
    Meagher, Margaret F.
    Bindayi, Ahmet
    McKay, Rana R.
    Autorino, Riccardo
    Staehler, Michael
    Derweesh, Ithaar H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (05) : 532 - 542
  • [24] Predictors and impact of microsurgical complications in patients with locally advanced oral squamous cell carcinoma
    Chen, Ya-Wei
    Chen, Chia-Yu
    Chiang, Shu-Chiung
    Lui, Man-Tin
    Kao, Shou-Yen
    Yang, Muh-Hwa
    CANCER SCIENCE, 2012, 103 (09) : 1672 - 1678
  • [25] Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone
    Chen, C. Y.
    Han, F.
    Zhao, C.
    Lu, L. X.
    Sun, Y.
    Liu, X. F.
    Lu, T. X.
    BRITISH JOURNAL OF RADIOLOGY, 2009, 82 (978): : 452 - 458
  • [26] Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence
    Zhao, Juping
    Zhu, Yu
    Zhang, Chongyu
    Wang, Xiaojing
    He, Hongchao
    Wang, Haofei
    Wu, Yuxuan
    Zhou, Wenlong
    Shen, Zhoujun
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1800 - 1805
  • [27] Pazopanib exposure response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy.
    Sternberg, Cora N.
    Donskov, Frede
    Haas, Naomi B.
    Doehn, Christian
    Russo, Paul
    Elmeliegy, Mohamed
    Banerjee, Hiya
    Aimone, Paola
    Voi, Maurizio
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
    Motzer, Robert J.
    Haas, Naomi B.
    Donskov, Frede
    Gross-Goupil, Marine
    Varlamov, Sergei
    Kopyltsov, Evgeny
    Lee, Jae Lyun
    Melichar, Bohuslav
    Rini, Brian I.
    Choueiri, Toni K.
    Zemanova, Milada
    Wood, Lori A.
    Reaume, M. Neil
    Stenzl, Arnulf
    Chowdhury, Simon
    Lim, Ho Yeong
    McDermott, Ray
    Michael, Agnieszka
    Bao, Weichao
    Carrasco-Alfonso, Marlene J.
    Aimone, Paola
    Voi, Maurizio
    Doehn, Christian
    Russo, Paul
    Sternberg, Cora N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) : 3916 - +
  • [29] Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables
    Sameh, Wael M.
    Hashad, Mohammed M.
    Eid, Ahmed A.
    Abou Yousif, Tamer A.
    Atta, Mohammed A.
    ARAB JOURNAL OF UROLOGY, 2012, 10 (02) : 131 - 137
  • [30] Predictors of postoperative survival in patients with locally advanced non-small cell lung carcinoma
    Iyoda, Akira
    Hiroshima, Kenzo
    Moriya, Yasumitsu
    Yoshida, Shigetoshi
    Suzuki, Makoto
    Shibuya, Kiyoshi
    Yoshino, Ichiro
    SURGERY TODAY, 2010, 40 (08) : 725 - 728